Literature DB >> 16612609

Macrolide use identified as risk factor for macrolide-resistant Streptococcus pneumoniae in a 17-center case-control study.

S E Beekmann1, D J Diekema, K P Heilmann, S S Richter, G V Doern.   

Abstract

The objective of the case-control study presented here was to examine the risk factors for macrolide-resistant Streptococcus pneumoniae. As part of a 44-center U.S. surveillance study, 1,817 unique isolates of S. pneumoniae were collected from November 2002 through April 2003. Seventy-five randomly selected macrolide-resistant isolates (cases) were each matched with one susceptible control. Macrolide use in the 6 weeks prior to sample collection was reported for seven cases and one control. The final conditional logistic regression model identified two statistically significant variables: a history of alcohol abuse was protective, while macrolide use in the 6 weeks prior to sample collection was a significant risk factor for macrolide-resistant S. pneumoniae. Macrolide resistance was associated with use of any antibiotic during the prior 6 weeks, and was most strongly associated with previous macrolide use.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16612609     DOI: 10.1007/s10096-006-0137-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  14 in total

Review 1.  Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review.

Authors:  A D Harris; T B Karchmer; Y Carmeli; M H Samore
Journal:  Clin Infect Dis       Date:  2001-03-21       Impact factor: 9.079

2.  Risk factors for penicillin resistance and mortality in Korean adults with Streptococcus pneumoniae bacteremia.

Authors:  B N Kim; L G Bae; M N Kim; S J Park; J H Woo; J Ryu; Y S Kim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-01       Impact factor: 3.267

3.  Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study.

Authors:  A J Clavo-Sánchez; J A Girón-González; D López-Prieto; J Canueto-Quintero; A Sánchez-Porto; A Vergara-Campos; P Marín-Casanova; J A Córdoba-Doña
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

4.  Influence of macrolide antibiotics on promotion of resistance in the oral flora of children.

Authors:  U Kastner; J P Guggenbichler
Journal:  Infection       Date:  2001-10       Impact factor: 3.553

5.  Predicting antimicrobial resistance in invasive pneumococcal infections.

Authors:  Otto G Vanderkooi; Donald E Low; Karen Green; Jeff E Powis; Allison McGeer
Journal:  Clin Infect Dis       Date:  2005-03-31       Impact factor: 9.079

6.  Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae.

Authors:  César García-Rey; Lorenzo Aguilar; Fernando Baquero; Julio Casal; Rafael Dal-Ré
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

7.  Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes?

Authors:  Gary V Doern; Sandra S Richter; Ashley Miller; Norma Miller; Cassie Rice; Kristopher Heilmann; Susan Beekmann
Journal:  Clin Infect Dis       Date:  2005-06-07       Impact factor: 9.079

Review 8.  Hidden epidemic of macrolide-resistant pneumococci.

Authors:  Keith P Klugman; John R Lonks
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

9.  Community prescribing and resistant Streptococcus pneumoniae.

Authors:  Galia Barkai; David Greenberg; Noga Givon-Lavi; Eli Dreifuss; Daniel Vardy; Ron Dagan
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

10.  Reference group choice and antibiotic resistance outcomes.

Authors:  Keith S Kaye; John J Engemann; Essy Mozaffari; Yehuda Carmeli
Journal:  Emerg Infect Dis       Date:  2004-06       Impact factor: 6.883

View more
  3 in total

Review 1.  Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance.

Authors:  Vered Schechner; Elizabeth Temkin; Stephan Harbarth; Yehuda Carmeli; Mitchell J Schwaber
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

2.  Beta-lactam versus beta- lactam/macrolide therapy in pediatric outpatient pneumonia.

Authors:  Lilliam Ambroggio; Matthew Test; Joshua P Metlay; Thomas R Graf; Mary Ann Blosky; Maurizio Macaluso; Samir S Shah
Journal:  Pediatr Pulmonol       Date:  2015-09-14

Review 3.  Antimicrobial agent exposure and the emergence and spread of resistant microorganisms: issues associated with study design.

Authors:  C Angebault; A Andremont
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-12-27       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.